相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
Chengsheng Ju et al.
RHEUMATOLOGY (2020)
Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention COLCHICINE-PCI Randomized Trial
Binita Shah et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2020)
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
Atsushi Tanaka et al.
PLOS MEDICINE (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Isla S. Mackenzie et al.
LANCET (2020)
Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study
Lisandro D. Colantonio et al.
ARTHRITIS RESEARCH & THERAPY (2020)
The Role of Colchicine in Treating Postoperative and Post-catheter Ablation Atrial Fibrillation
Spyridon G. Deftereos et al.
CLINICAL THERAPEUTICS (2019)
Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis
Chi-Hua Chen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Safety and tolerability of available urate-lowering drugs: a critical review
Larysa Strilchuk et al.
EXPERT OPINION ON DRUG SAFETY (2019)
The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction
Thomas Hennessy et al.
AMERICAN HEART JOURNAL (2019)
Colchicine as a Novel Therapy for Suppressing Chemokine Production in Patients With an Acute Coronary Syndrome: A Pilot Study
Bradley Tucker et al.
CLINICAL THERAPEUTICS (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes A meta-analysis
Cai-Yan Zou et al.
MEDICINE (2019)
The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: A phase 4 randomized, placebo-controlled, double-blind, crossover trial
Allison G. Hays et al.
AMERICAN HEART JOURNAL (2018)
Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
Markus Bredemeier et al.
BMC CARDIOVASCULAR DISORDERS (2018)
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
MaryAnn Zhang et al.
CIRCULATION (2018)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome A CT Coronary Angiography Study
Kaivan Vaidya et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert
Hyon Choi et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study
Benjamin W. Van Tassell et al.
CLINICAL CARDIOLOGY (2018)
Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF ) Study Design
Takashi Yokota et al.
INTERNATIONAL HEART JOURNAL (2018)
Colchicine for primary prevention of atrial fibrillation after open-heart surgery: Systematic review and meta-analysis
Carsten Lennerz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Colchicine in cardiovascular disease: an ancient drug with modern tricks
David C. Tong et al.
HEART (2016)
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
Isla S. Mackenzie et al.
BMJ OPEN (2016)
A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout
Jeffrey Poiley et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims
Jasvinder A. Singh et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats
Bhaskar Krishnamurthy et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction A Pilot Study
Spyridon Deftereos et al.
CIRCULATION (2015)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)
Yehuda Adler et al.
EUROPEAN HEART JOURNAL (2015)
Allopurinol use and risk of non-fatal acute myocardial infarction
Francisco J. de Abajo et al.
HEART (2015)
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis
Shulin Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Impact of allopurinol on risk of myocardial infarction
L. Grimaldi-Bensouda et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation The COPPS-2 Randomized Clinical Trial
Massimo Imazio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta-Analysis
Vikram Agarwal et al.
JOURNAL OF CLINICAL HYPERTENSION (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
Spyridon Deftereos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
Sushma Rekhraj et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout
Daria B. Crittenden et al.
JOURNAL OF RHEUMATOLOGY (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction
Eswar Krishnan et al.
ARTHRITIS RESEARCH & THERAPY (2012)
COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial
Massimo Imazio et al.
EUROPEAN HEART JOURNAL (2010)
Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
Michael A. Becker et al.
JOURNAL OF RHEUMATOLOGY (2009)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
H. R. Schumacher et al.
RHEUMATOLOGY (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase
Michael A. Becker et al.
ARTHRITIS AND RHEUMATISM (2005)
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies
W Doehner et al.
CIRCULATION (2002)
分享论文
